Technologies

Life Sciences & Biotechnology

Title:

mRNA vaccine technology

Area:

Life Sciences & Biotechnology

Focus Area:

Vaccines, Infectious Diseases

Status:

Market authorization is received for COVID 19 and Omicron specific Covid 19 vaccine

Patent:

Filed

Social Benefits:

Thermostable mRNA vaccine platform technology is empowering inida for pandemic preparedness

Developing Agency:

Gennova, Pune

Technology Readiness Index:

TRL-9

Brief Description

Description :

DBT-BIRAC supported India's first thermostable mRN vaccine to prevent COVID-19 by Gennova Pharmaceuticals limited

Related Technologies